NCT05543577

Brief Summary

General objective: to measure the preparedness of pharmacists and medical interns about monkeypox Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 14, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 16, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

December 5, 2023

Status Verified

November 1, 2023

Enrollment Period

2 months

First QC Date

September 14, 2022

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using an online Questionnaire

    the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using a validated questionnaire

    2 months

  • Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases

    Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases

    2 months

Study Arms (2)

Pharmacists

community, hospital and clinical pharmacists

Other: Questionnaire

Medical interns

Medical interns of both sexes

Other: Questionnaire

Interventions

Questionnaire

Medical internsPharmacists

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

community, hospital and clinical pharmacists, Medical interns of both sexes and any age

You may qualify if:

  • \- community, hospital and clinical pharmacists, Medical interns of both sexes

You may not qualify if:

  • any other healthcare professional

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BeniSuefU

Minya, Egypt

Location

Related Links

MeSH Terms

Conditions

Mpox, Monkeypox

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Poxviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsPrimate DiseasesAnimal DiseasesRodent Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Engy Wahsh, Ph.D.

    6october University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

September 14, 2022

First Posted

September 16, 2022

Study Start

September 14, 2022

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

December 5, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

only the PI will keep the data and have access to the questionnaire

Locations